跳至主要内容
临床试验/DRKS00011487
DRKS00011487已完成4 期

Pilot study to evaluate glycemic control withGlucoTab using an ultra-long acting insulinanalogue in non-critically ill patients with type 2diabetes at the general ward - GlucoTab_U300

niversitätsklinik für Innere Medizin, Abteilung für Endokrinologie und Diabetologie0 个研究点目标入组 30 人开始时间: 2017年1月25日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
N/a: Single Arm Study
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 100 Years(—)
性别
All

入选标准

  • Informed Consent obtained after being advised of the nature of the study
  • Male or female aged = 18 years
  • Type 2 Diabetes (treated with diet, oral agents, non-insulin injected antidiabetic medicine, insulin therapy or any combination of the four) or newly diagnosed hyperglycemia which requires s.c insulin therapy

排除标准

  • Type 1 Diabetes or gestational diabetes
  • Any disease or condition which the investigator feels would interfere with the trial or the safety of the patient
  • Any mental condition rendering the patient incapable of giving his consent
  • Continous parenteral nutrition
  • Participation in another clinical study which can influence the software algorithm

研究者

发起方
niversitätsklinik für Innere Medizin, Abteilung für Endokrinologie und Diabetologie

相似试验

Pilot study to evaluate glycemic control... | 临床试验